Key result
High-dose ascorbate completely prevents primary tumor development in Lp(a) mice compared to wild-type controls.
Answers are grounded in this paper and cite their sources.
Cancer progression is characterized by loss of extracellular matrix (ECM) integrity, which is a precondition for tumor growth and metastasis. In order to elucidate the precise mechanisms of ECM degradation in cancer we used a genetically modified mouse mimicking two distinct human metabolic features associated with carcinogenesis, the lack of endogenous vitamin C synthesis and the production of human Lp(a). Female Lp(a)+; Gulo(-/-) and control wild-type Balb/c mice without these two metabolic features were orthotopically inoculated with 4T1 breast cancer cells (5x105). The transgenic and control mice were divided into 4 different dietary groups in respect to dietary vitamin C intake: i) low ascorbate intake for 6 weeks; ii) high ascorbate intake for 6 weeks; iii) low ascorbate intake for 3 weeks followed by high ascorbate for 3 weeks; iv) high ascorbate intake for 3 weeks followed by low ascorbate for 3 weeks. After 6 weeks, all wild-type mice developed tumors. In contrast, Lp(a)+; Gulo(-/-) mice developed one third less primary tumors (low ascorbate diet) or no primary tumors at all (high ascorbate diet). Significantly, tumors from Lp(a)+; Gulo(-/-) mice immunostained positively for Lp(a) and their size was inversely proportional to Lp(a) serum levels. The results implicate that Lp(a) may play a role in controlling tumor growth and expansion. The most likely mechanism is the competitive inhibition of plasmin-induced ECM degradation due to the homology of Lp(a) components to plasminogen. The confirmation of this pathomechanism could lead to a universal therapeutic target for the prevention and treatment of cancer.
No takes yet. Share an insight, caveat, or question.
Roomi et al. (2016) studied Breast cancer (4T1 mouse model). Human Lp(a) expression and dietary vitamin C (ascorbate) supplementation vs. Wild-type Balb/c mice and low ascorbate diet regimens was evaluated on Primary breast cancer tumor development at 6 weeks. Lp(a)+; Gulo(-/-) mice developed 0% primary tumors on a high ascorbate diet and one-third fewer tumors on a low ascorbate diet compared to 100% tumor development in wild-type mice.
Synapse has enriched 10 related papers. Consider them for comparative context: